1. Home
  2. FLGT vs STK Comparison

FLGT vs STK Comparison

Compare FLGT & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • STK
  • Stock Information
  • Founded
  • FLGT 2011
  • STK 2009
  • Country
  • FLGT United States
  • STK United States
  • Employees
  • FLGT N/A
  • STK N/A
  • Industry
  • FLGT Medical Specialities
  • STK Investment Managers
  • Sector
  • FLGT Health Care
  • STK Finance
  • Exchange
  • FLGT Nasdaq
  • STK Nasdaq
  • Market Cap
  • FLGT 683.5M
  • STK 553.2M
  • IPO Year
  • FLGT 2016
  • STK N/A
  • Fundamental
  • Price
  • FLGT $17.87
  • STK $33.49
  • Analyst Decision
  • FLGT Hold
  • STK
  • Analyst Count
  • FLGT 2
  • STK 0
  • Target Price
  • FLGT $28.50
  • STK N/A
  • AVG Volume (30 Days)
  • FLGT 273.1K
  • STK 38.2K
  • Earning Date
  • FLGT 11-08-2024
  • STK 01-01-0001
  • Dividend Yield
  • FLGT N/A
  • STK 6.60%
  • EPS Growth
  • FLGT N/A
  • STK N/A
  • EPS
  • FLGT N/A
  • STK N/A
  • Revenue
  • FLGT $277,761,000.00
  • STK N/A
  • Revenue This Year
  • FLGT N/A
  • STK N/A
  • Revenue Next Year
  • FLGT $14.04
  • STK N/A
  • P/E Ratio
  • FLGT N/A
  • STK N/A
  • Revenue Growth
  • FLGT N/A
  • STK N/A
  • 52 Week Low
  • FLGT $16.56
  • STK $24.95
  • 52 Week High
  • FLGT $30.68
  • STK $34.31
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 40.87
  • STK 54.19
  • Support Level
  • FLGT $16.56
  • STK $32.86
  • Resistance Level
  • FLGT $18.61
  • STK $33.46
  • Average True Range (ATR)
  • FLGT 1.11
  • STK 0.46
  • MACD
  • FLGT -0.25
  • STK -0.00
  • Stochastic Oscillator
  • FLGT 20.76
  • STK 67.11

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About STK Columbia Seligman Premium Technology Growth Fund Inc

Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.

Share on Social Networks: